Camphorquinone-10-sulfonic acid hydrate was prepared by the action of selenous acid on camphor-lO-sulfonic acid. Camphorquinone-10-sulfonylnorleucine was prepared either from the sulfonic acid via the sulfonyl chloride or by selenous acid oxidation of camphor-lO-sulfonylnorleucine. These reagents are useful for specific, reversible modification of the guanidino groups of arginine residues. Camphorquinonesulfonic acid is a crystalline water-soluble reagent that is especially suitable for use with small arginine-containing molecules, because the sulfonic acid group of the reagent is a convenient handle for analytical and preparative separation of products. Camphorquinonesulfonylnorleucine is more useful for work with large polypeptides and proteins, because hydrolysates of modified proteins may be analyzed for norleucine to determine the extent of arginine modification. The adducts of the camphorquinone derivatives with the guanidino group are stable to 0.5 M hydroxylamine solutions at pH 7, the recommended conditions for cleavage of the corresponding cyclohexanedione adducts. At pH 8-9 the adducts of the camphorquinone derivatives with the guanidino group are cleaved by o-phenylenediamine. The modification and regeneration of arginine, of the dipeptide arginylaspartic acid, of ribonuclease S-peptide, and of soybean trypsin inhibitor are presented as demonstrations of the use of the reagents. The use of camphorquinonesulfonyl chloride to prepare polymers containing arginine-specific ligands is discussed.
Patthy and Smith (1) have reported a method for specific, reversible modification of arginine residues in peptides and proteins. Cyclohexanedione was shown to add to the guanidino group of arginine to yield the N7,N8-(1,2-dihydroxycyclohex-1,2-yl)arginine derivative, which is subject to cleavage by 0.5 M hydroxylamine at pH 7. We now report the synthesis of camphorquinone-10-sulfonic acid § (Cqs-OH) ( Fig. 1) , a bifunctional reagent in which one functional group is a specific, reversible ligand for the side chain of arginine and the second functional group can be used for covalent attachment of the molecule to chemical markers or to polymeric supports. The adduct of Cqs-OH with arginine is stable to 0.5 M hydroxylamine at pH 7, but it is cleaved by incubation with 0.2 M ophenylenediamine at pH 8-9. There is a sharp change in ionic properties when an arginine residue is blocked with Cqs-OH or when a free guanidino group is released from the Cqs-OH adduct. These changes during modification and regeneration of arginine residues facilitate chromatographic and electrophoretic separations of products from starting materials, especially with small arginine-containing peptides.
The Cqs-OH adduct with arginine is unstable to hydrolysis in 6 M HCI at 1100C. Arginine is quantitatively regenerated during hydrolysis so that amino acid analyses of peptides do not change after Cqs-OH modification. When larger argininecontaining peptides or proteins are treated with Cqs-OH it is difficult to estimate the extent of arginine modification. Camphorquinonesulfonylnorleucine (Cqs-Nle-OH) (Fig. 2) is the reagent of choice under these circumstances. This material, like Cqs-OH, reacts specifically with the arginine residues of polypeptides. The degree of arginine modification is easily determined in acid hydrolysates of modified proteins because one mole of norleucine appears in the amino acid analysis for each mole of reagent incorporated into the protein. Reversal of the arginine modification is accomplished by the same treatment used to cleave the Cqs-OH adduct. Completeness of the cleavage of the blocking group can be checked by the disappearance of norleucine from acid hydrolysates of the regenerated polypeptide. To demonstrate use of the reagent we have treated soybean trypsin inhibitor (STI) and ribonuclease S-peptide (2) with Cqs-Nle-OH. The modified proteins yielded arginine and norleucine in a 1:1 molar ratio after acid hydrolysis, and the modified trypsin inhibitor was devoid of all trypsin inhibitory activity (3) . After removal of the Cqs-Nle-OH by o-phenylenediamine, the regenerated STI and the ribonuclease S-peptide yielded only traces of norleucine upon acid hydrolysis. The trypsin inhibitory activity of the STI was restored to 93-94% of that of the native protein.
Camphorquinonesulfonyl chloride is potentially useful for introducing arginine-specific ligands into a variety of reagents. Several camphorquinonesulfonyl polymer derivatives have been prepared and shown to specifically and reversibly bind arginine. Such polymers might be applied in the isolation of peptides and in the semisynthesis of polypeptides. (ii) Norleucine (0.5 g) was dissolved in warm water (30 ml) and the solution was cooled to room temperature. Dioxane (20 ml) and MgO (1.4 g) were added to the solution, followed by camphorquinonesulfonyl chloride (1.7 g) in four portions over a period of 24 hr. After 34 hr the mixture was filtered and the product was isolated by the method used for camphorsulfonylnorleucine. The product was identical to the compound obtained by selenous acid oxidation of camphorsulfonylnorleucine. Hydrolysis in 6 M HCI at 1100 C for 22 hr gave quantitative recovery of norleucine.
Reversible Modification of Ribonuclease S-Peptide with Cqs-Nle-OH. Ribonuclease S-peptide (10 mg) was added to a solution of Cqs-Nle-OH (20 mg) in 4 ml of 0.2 M sodium borate buffer, pH 9.0, and the mixture was incubated at 370C for 24 hr in the dark. The resulting solution was dialyzed against 0.2 M acetic acid on an ultrafilter with a molecular weight cutoff of 2000, then Iyophilized. An acid hydrolysate of the S-peptide derivative yielded amino acids in the expected molar ratios except that there was one mole of norleucine present per mole of arginine in the peptide hydrolysate.
Cqs-Nle-OH-modified ribonuclease S-peptide (8 mg) was dissolved in 2 ml of 0.2 M o-phenylenediamine, pH 9.0, and the pH of the solution was readjusted to 9.0. The solution was left at 37°C for 24 hr, after which it was subjected to ultrafiltration as above and the ultrafiltered polypeptide was recovered by Iyophilization. Amino acid analyses of acid hydrolysates were unchanged from those of the original S-peptide (norleucine content less than 0.01 residue per mole).
Reversible Modification of STI with Cqs-Nle-OH. STI (40 mg) was added to a solution of Cqs-Nle-OH (75 mg) in 6 ml of 0.2 M sodium borate buffer, pH 9.0. The mixture was incubated in the dark at 37°C for 24 hr. The solution was dialyzed against deionized water (2 X 2 liters) and against 0.2 M acetic acid (2 X 2 liters) at 4°C, then Iyophilized. Samples of the product hydrolyzed in 6 M HCI yielded an amino acid analysis unchanged from that of the unmodified protein except that norleucine was present in a 1:1 molar ratio with the arginine content.
Cqs-Nle-OH-modified STI (20 mg) was dissolved in 2 ml of 0.2 M o-phenylenediamine and the pH of the solution was adjusted to 9.0. The solution was left at 37°C for 24 hr, after which it was dialyzed against water (twice, 2 liters each) and against 0.2 M acetic acid (three times, 2 liters each), then lyBiochemistry: Pande et al.
ophilized. Amino acid analysis of acid hydrolysates showed amino acid composition unchanged from native STI, with barely a trace of norleucine present.
Native, modified, and regenerated STI were assayed by the method of Green and Shaw (10) for trypsin inhibitory activity. STI modified with Cqs-Nle-OH had no inhibitory activity and the regenerated protein was found to possess 93% of the inhibitory activity of native STI. In the gel electrophoresis system described for analysis of Cqs-OH-modified STI, the Cqs-Nle-OH-treated protein moved ahead of STI. Regenerated STI migrated with the native protein.
DISCUSSION
Of the 20 amino acids commonly found in acid hydrolysates of proteins, only arginine and cystine showed any reaction with Cqs-OH in borate buffers at pH 9. Because there was no indication of cystine loss during modification of arginine residues in polypeptides during subsequent experiments, the loss of some cystine in this study is apparently characteristic of the free amino acid.
The arginine/Cqs-OH adduct was isolated as a powder after formation in borate buffers at pH 9. It was homogeneous by thin-layer chromatography and by high-voltage electrophoresis. Ion-exchange chromatography in a standard protein hydrolysate analysis system showed a doublet eluting between glutamic acid and glycine. Whether the doublet indicates initial formation of isomeric adducts during the treatment of arginine with Cqs-OH or whether the doublet results from chemical changes in a single product during chromatography in acidic buffers at 550C is not clear. Treatment with o-phenylenediamine causes complete regeneration of arginine, whether from a single adduct or from a mixture of two. The arginine/Cqs-OH adduct is stable for 24 hr in trifluoroacetic acid, in 2.7 M HBr in acetic acid, and in 1 M HC1 in acetic acid. It remains unchanged in 10% (vol/vol) 2-mercaptoethanol in 0.1 M phosphate buffer, pH 7, for at least 4 hr. The material is not decomposed by 0.5 M hydroxylamine at pH 7. This suggests that cyclohexanedione adducts with guanidino groups might be selectively removed in the presence of Cqs-OH adducts. The two dione derivatives may thus represent a set of independently removable arginine-modifying reagents.
The modification of arginine and subsequent reversal of the modification were carried out on arginylaspartic acid and on the 20-residue ribonuclease S-peptide. The course of the modification and regeneration of the arginine residues were followed by high-voltage electrophoresis. The modified peptides showed decreased electrophoretic mobility at pH 3.5 compared to the unmodified peptides. For complete regeneration of arginine-containing peptides, it was necessary to have the peptide derivatives free of borate salts before treatment with o-phenylenediamine. This was arranged either by avoiding borate buffers in the first place or by desalting after modification of the arginine residues.
N7,N8-(1,2-Dihydroxycyclohex-1,2-yl)arginine, the hydroxylamine-labile adduct of cyclohexanedione with arginine, undergoes several side reactions in alkaline solutions, especially in the absence of stabilizing borate ions. At least one of the side reactions, involving contraction of the cyclohexane ring, leads to irreversible modification of the arginine side chain. In the Cqs-OH moiety, analogous ring contraction of the bicyclo[2.2.1]heptane system requires transformation into the highly strained bicyclo[2.1. 1]hexane system (11) . Such transformations have been reported to occur only under the action of strong acids in nonaqueous media (12) (13) (14) or photochemically from appropriate diazoketones (15) (16) . Even strongly alkaline conditions as used in the benzilic acid or Favorskii rearrangements have failed to effect ring contractions in appropriately substituted bicyclo[2.2. 1]heptanes (17) .
Cqs-Nle-OH acts as a specific, reversible reagent for modification of arginine residues and carries, at the same time, a chemical marker for quantitative estimation of the extent of arginine modification. Because the Cqs-Nle-OH-modified arginine residue yields free arginine and norleucine during hydrolysis of modified polypeptides, it is possible to measure directly the degree of arginine modification from routine amino acid analysis of acid hydrolysates. When STI was treated with Cqs-OH in borate buffers, for example, the trypsin-inhibitory activity of the protein was abolished. The modified protein was distinguishable from the native protein by gel electrophoresis, but the number of arginine residues modified was not clear. When the same protein was treated with Cqs-Nle-OH rather than with Cqs-OH, the biological activity was abolished and amino acid hydrolysates showed arginine and norleucine in a 1:1 molar ratio, indicating complete modification of the arginine residues of the molecule. Treatment with o-phenylenediamine left a regenerated STI that yielded almost no norleucine on acid hydrolysis and that had recovered 93-94% of its trypsin-inhibitory activity. The loss of biological activity upon modification of the arginine residues of the trypsin inhibitor (3) is consistent with the previously demonstrated involvement of the arginine residues in the action of the inhibitor, and the reversal of the arginine modification with recovery of biological activity demonstrates that the molecule was not damaged by the conditions of the arginine blocking and deblocking procedures.
Camphorquinonesulfonyl chloride reacts with polyethyleneglycol to yield a polymer derivative that specifically and reversibly binds arginine and arginine-containing peptides. The sulfonic ester bond between polymer and arginine-specific ligand is somewhat susceptible to hydrolysis in basic media. More stable bonds between ligand and polymer are obtained by interposing an amino acid residue between the polymer and the camphorquinonesulfonyl group (18) or by converting the hydroxyl groups of the polyethyleneglycol to amino groups followed by treatment with camphorquinonesulfonyl chloride to obtain a sulfonamide linkage. Polymer derivatives of this type have been prepared; they might serve as carriers during semisynthesis of polypeptides in aqueous solutions. Attachment to supports through arginine side chains serves a dual purpose when trypsin-labile blocking groups are used in semisynthetic operations (19) (20) (21) , and the arginine residues of the peptide chain must be temporarily modified during tryptic removal of blocking groups.
